Skip to main content
. 2024 Dec 3;15:10530. doi: 10.1038/s41467-024-54910-x

Fig. 6. Percentage of patients with “Response to Treatment”, “Inconclusive” and “No Response to Treatment” results revealed by conventional, recombinant and MultiCruzi ELISA tests at 12 months following treatment.

Fig. 6

For the conventional and recombinant ELISA, the percentage was calculated by setting a threshold of minimum 20% in seroreduction at 12 months post-treatment. For MultiCruzi, the threshold for the decrease of the log2DF50 is −0.3. Conv Conventional, Rec Recombinant, BZN Benznidazole.